1. Rifaximin, a pregnane X receptor (PXR) activator regulates apoptosis in a murine model of breast cancer
   Swetlana Gautam et al, 2018, RSC Adv. CrossRef
2. Glucose-dependent regulation of pregnane X receptor is modulated by AMP-activated protein kinase
   Peter O. Oladimeji et al, 2017, Sci Rep CrossRef
3. Herb–Drug Interaction Potential of Licorice Extract and Paclitaxel: A Pharmacokinetic Study in Rats
   Yinuer Ha et al, 2019, Eur J Drug Metab Pharmacokinet CrossRef
4. Xiaoaiping injection enhances paclitaxel efficacy in ovarian cancer via pregnane X receptor and its downstream molecules
   Xiang-Qi Zhang et al, 2020, Journal of Ethnopharmacology CrossRef
5. The Anti-Cancer Drug Dabrafenib Is a Potent Activator of the Human Pregnane X Receptor
   Nicolas Creusot et al, 2020, Cells CrossRef
6. Involvement of ABC transporters in the detoxification of non-substrate nanoparticles in lung and cervical cancer cells
   Tongkuo Yuan et al, 2021, Toxicology CrossRef
7. The role of the microbiome in ovarian cancer: mechanistic insights into oncobiosis and to bacterial metabolite signaling
   Adrienn Sipos et al, 2021, Mol Med CrossRef
8. Target Hopping from Protein Kinases to PXR: Identification of Small-Molecule Protein Kinase Inhibitors as Selective Modulators of Pregnane X Receptor from TüKIC Library
   Enni-Kaisa Mustonen et al, 2022, Cells CrossRef
9. The role of bile acids in carcinogenesis
   Tadeja Režen et al, 2022, Cell. Mol. Life Sci. CrossRef
10. Ketoconazole Reverses Imatinib Resistance in Human Chronic Myelogenous Leukemia K562 Cells
    Omar Prado-Carrillo et al, 2022, IJMS CrossRef
11. Functionalized PEG-PLA nanoparticles for brain targeted delivery of ketoconazole contribute to Pregnane X receptor overexpressing in drug-resistant epilepsy
    Jianhong Wang et al, 2022, Epilepsy Research CrossRef
12. Gefitinib Inhibits Rifampicin-Induced CYP3A4 Gene Expression in Human Hepatocytes
    Kodye L. Abbott et al, 2022, ACS Omega CrossRef
13. Combination of Paclitaxel and PXR Antagonist SPA70 Reverses Paclitaxel-Resistant Non-Small Cell Lung Cancer
    Xiaxia Niu et al, 2022, Cells CrossRef
14. The Role of CYP3A in Health and Disease
    Lyubov S. Klyushova et al, 2022, Biomedicines CrossRef
15. Cisplatin increases carboxylesterases through increasing PXR mediated by the decrease of DEC1
    Minqin Xu et al, 2023, J Biomed Res CrossRef
16. I-CBP112 declines overexpression of ATP-binding cassette transporters and sensitized drug-resistant MDA-MB-231 and A549 cell lines to chemotherapy drugs.
    Magdalena Strachowska et al, 2023, Biomed Pharmacother CrossRef
17. Novel players in the development of chemoresistance in ovarian cancer: ovarian cancer stem cells, non-coding RNA and nuclear receptors
    Shahil Alam et al, 2024, Cancer Drug Resist CrossRef
18. The Interface between Cell Signaling Pathways and Pregnane X Receptor
    Robert S. Rogers et al, 2021, Cells CrossRef
19. First-in-Class Small Molecule Degrader of Pregnane X Receptor Enhances Chemotherapy Efficacy
    Andrew D. Huber et al, 2024, J. Med. Chem. CrossRef
20. Human Cytochrome P450 Cancer-Related Metabolic Activities and Gene Polymorphisms: A Review
    Innokenty M. Mokhosoev et al, 2024, Cells CrossRef